The second study was a prospective cohort study of 19 patients in which D'Egidio et al. [12] followed patients from Ottawa, Canada with CD4 counts having plateaued at <200 cells/μL and undetectable VL while off PCP prophylaxis. This evidence concerns the gene MLC1 and pneumocystosis.